Review Finds No Standard Treatment for Brain Injury

A new study reveals that clinical management for agitation after brain injury lacks a consistent evidence-based approach.

Updated on Oct. 23, 2026 in Alzheimer’s

Isometric editorial illustration of a sterile clinical room door in a quiet hallway, representing standardized care research.
A new scoping review identifies a significant lack of standardized, evidence-based clinical protocols for treating patient agitation following traumatic brain injury. AI Illustration. Upload story photo >

Live Poll

Should doctors prioritize personalized treatment plans over standardized protocols for patient care?

A scoping review published on August 11, 2026, highlights a lack of standardized clinical evidence for managing patient agitation following traumatic brain injury. This condition affects up to 70% of individuals in rehabilitation settings, making consistent care strategies a critical priority for providers.

Why it matters

Currently, there are no established clinical protocols for treating agitation after a brain injury, complicating recovery and care. This review underscores the urgent need for larger clinical trials to transition from anecdotal approaches to evidence-based management.

The scoping review analyzed 13 studies identified from 65 initial records published between January 2015 and March 2026. While small-scale data suggest potential benefits of olanzapine in 11 patients and valproic acid in 3 males, larger studies are required to confirm clinical efficacy.

The players

Chinese Neurosurgical Journal

An academic publication headquartered in Beijing that focuses on advancing neurosurgical research and practice.

The details

Researchers searched medical databases to evaluate how clinicians address agitation, which is common in traumatic brain injury survivors. Current clinical practices often rely on non-pharmacological interventions like environmental noise reduction and the use of single-occupancy rooms. Pharmacological treatments, including antipsychotics and mood stabilizers, have only been examined in limited trials and case reports, precluding a definitive standard of care.

Timeline

  1. January 2015 to March 2026: period covered by the research literature search.

  2. 2020: the year 214,000 traumatic brain injury hospitalizations were recorded in the U.S.

  3. August 11, 2026: the date the scoping review was published.

Health Landscape

This scoping review mirrors the rigor found in systematic evaluations of medical literature, such as those cataloged in the Cochrane database. It highlights a critical departure from evidence-based practice in neurotrauma, where practitioners currently lack a unified framework to manage agitation.

If you are caring for a loved one recovering from a brain injury, recognize that agitation is a common clinical challenge rather than a behavioral failure. Discuss current, non-pharmacological management strategies like environment modification with their care team to understand what is being utilized.

The takeaway

Management of post-injury agitation is currently evolving and lacks a singular, proven protocol. Families should maintain an open dialogue with neurologists regarding which interventions—whether environmental or medical—are being prioritized for their specific situation.

Further reading

For broader insights into how brain health affects behavior, visit our Alzheimer’s section.

More information

Review the full findings in the original research paper.

Live Poll

Should doctors prioritize personalized treatment plans over standardized protocols for patient care?